CRAM: Antibody mixture platform
-
Enabling generation multiple mAbs
or Fc fusions from
single stable cell line
-
PCT filed; Validated for
EGFR-targeted mAb mixture
-
No process issue, no stability issue;
-
Product life cycle management: applicable
for combinations of
clinical validated mAb
